FeesSafety
Pluang+

US large-cap stocks fall amid mixed Q3 earnings and Fed rate hold with economic optimism.

Market News
03 Nov 2026, 14:30 WIB
Seeking Alpha
View Source
Neutral
US large-cap stocks fall amid mixed Q3 earnings and Fed rate hold with economic optimism.

Major US large-cap indexes declined in volatile trading as investors reacted to third-quarter earnings from AI-related tech firms. The Federal Reserve kept interest rates steady but noted strong economic growth and persistent inflation, with two members favoring a rate hike. Bond yields fell, with 10-year Treasury rates closing below 5%, while municipal bonds had their best October since 1980, recovering September losses. This mixed market reflects cautious optimism amid ongoing inflation concerns and tech sector volatility.

Cumberland's Monday Memo covers a market day where 56 of 142 Financials-sector US stocks on Pluang rose, while 77 fell. Notable movers include Raymond James Financial, Inc. (RJF) down 3.11% at USD 157.25 with a typical hold time of 77 days, Carlyle Group Inc (CG) down 2.09% at USD 40.20 with a 112-day hold, and Hut 8 Corp (HUT) up 1.81% at USD 56.00 with a 12-day hold and 100% sell order activity. This snapshot is as of Nov 03, 2026 18:42 WIB.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
21 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App